CH581140A5 - - Google Patents

Info

Publication number
CH581140A5
CH581140A5 CH788872A CH788872A CH581140A5 CH 581140 A5 CH581140 A5 CH 581140A5 CH 788872 A CH788872 A CH 788872A CH 788872 A CH788872 A CH 788872A CH 581140 A5 CH581140 A5 CH 581140A5
Authority
CH
Switzerland
Application number
CH788872A
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of CH581140A5 publication Critical patent/CH581140A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
CH788872A 1971-05-28 1972-05-26 CH581140A5 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14812971A 1971-05-28 1971-05-28
US273550A US3860577A (en) 1971-05-28 1972-07-20 Aminoazetidinoneacetic acid esters

Publications (1)

Publication Number Publication Date
CH581140A5 true CH581140A5 (fr) 1976-10-29

Family

ID=26845547

Family Applications (4)

Application Number Title Priority Date Filing Date
CH788872A CH581140A5 (fr) 1971-05-28 1972-05-26
CH1486774A CH568975A5 (fr) 1971-05-28 1972-05-26
CH997573A CH563974A5 (fr) 1971-05-28 1972-05-26
CH5976A CH586197A5 (fr) 1971-05-28 1972-05-26

Family Applications After (3)

Application Number Title Priority Date Filing Date
CH1486774A CH568975A5 (fr) 1971-05-28 1972-05-26
CH997573A CH563974A5 (fr) 1971-05-28 1972-05-26
CH5976A CH586197A5 (fr) 1971-05-28 1972-05-26

Country Status (8)

Country Link
US (1) US3860577A (fr)
JP (3) JPS53127459A (fr)
BE (1) BE784084A (fr)
CH (4) CH581140A5 (fr)
DE (1) DE2225697A1 (fr)
FR (1) FR2139965B1 (fr)
GB (1) GB1346744A (fr)
NL (1) NL7207209A (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301278A (en) * 1974-02-26 1981-11-17 Ciba-Geigy Corporation Process for the manufacture of enol derivatives
GB1510794A (en) * 1974-08-06 1978-05-17 Univ Kingston 1-oxacephems and intermediates therefor
CA1041523A (fr) * 1974-06-19 1978-10-31 Queen's University Preparation d'oxapenicilline-1 et nouveaux produits intermediaires que l'on peut en tirer
US4147864A (en) * 1975-02-20 1979-04-03 Ciba-Geigy Corporation Process for the manufacture of 7β-amino-3-cephem-3-ol-4 carboxylic acid compounds
US4187221A (en) * 1976-12-31 1980-02-05 Connlab Holdings Limited Process for preparing azetidinones
GR81665B (fr) * 1983-02-02 1984-12-12 Univ Notre Dame Du Lac
JPS6327385A (ja) * 1986-07-16 1988-02-05 株式会社日立ビルシステムサービス 巻胴式エレベ−タ
JPH0523717Y2 (fr) * 1987-11-09 1993-06-17

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1935970A1 (de) * 1968-07-23 1970-01-29 Ciba Geigy Oxyessigsaeureverbindungen

Also Published As

Publication number Publication date
CH568975A5 (fr) 1975-11-14
CH563974A5 (fr) 1975-07-15
NL7207209A (fr) 1972-11-30
FR2139965B1 (fr) 1978-09-08
JPS53127459A (en) 1978-11-07
JPS5686151A (en) 1981-07-13
GB1346744A (en) 1974-02-13
CH586197A5 (fr) 1977-03-31
JPS53127458A (en) 1978-11-07
FR2139965A1 (fr) 1973-01-12
JPS5823875B2 (ja) 1983-05-18
DE2225697A1 (de) 1972-12-14
US3860577A (en) 1975-01-14
JPS5823874B2 (ja) 1983-05-18
JPS5633393B2 (fr) 1981-08-03
BE784084A (fr) 1972-11-27

Similar Documents

Publication Publication Date Title
ATA136472A (fr)
AU2658571A (fr)
AU2691671A (fr)
AU2485671A (fr)
AU3005371A (fr)
AU2952271A (fr)
AU2941471A (fr)
AU2894671A (fr)
AU2742671A (fr)
AU2684071A (fr)
AU2564071A (fr)
AU2473671A (fr)
AU2399971A (fr)
AU3038671A (fr)
AU2486471A (fr)
AU3025871A (fr)
AU2503871A (fr)
AU2456871A (fr)
AU2577671A (fr)
AU2588771A (fr)
AU2654071A (fr)
AU2455871A (fr)
AU2669471A (fr)
AU2415871A (fr)
AU2684171A (fr)

Legal Events

Date Code Title Description
PL Patent ceased